期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
兔骨折合并脑外伤模型血清对鼠骨折愈合影响的实验研究 被引量:1
1
作者 杨运发 林博川 +2 位作者 李远辉 张光明 徐中和 《临床医学工程》 2010年第11期25-27,共3页
目的在鼠单纯骨折模型中应用兔骨折合并脑外伤模型血清,分析其骨折愈合过程。方法制备兔骨折合并脑外伤模型8只,并制备兔骨折合并脑外伤模型动物不同时段血清(实验血清),分术后1w、2w、3w、4w分别保存,冻干处理;从2只健康兔动脉血制备血... 目的在鼠单纯骨折模型中应用兔骨折合并脑外伤模型血清,分析其骨折愈合过程。方法制备兔骨折合并脑外伤模型8只,并制备兔骨折合并脑外伤模型动物不同时段血清(实验血清),分术后1w、2w、3w、4w分别保存,冻干处理;从2只健康兔动脉血制备血清(阴性对照血清),冻干处理;制备鼠单纯股骨干骨折模型72只,骨折行克氏针髓内固定;将单纯股骨干骨折模型鼠随机分成3组,即实验组、阴性对照组和空白对照组,每组24只,据鼠与兔体表面积比计算血清用量,实验组在术后1天(第1周)、8天(第2周)、15天(第3周)、22天(第4周)分别臀肌内注射相应时段实验血清,阴性对照组对应时间肌注阴性对照血清,空白对照组不予任何处理;每组术后1w、2w、3w、4w处死6只鼠,X线摄片比较各组骨折固定术后1w、2w、3w、4w骨折愈合情况。软件分析骨痂形成情况。结果术后2w、3w、4w实验组较对照组骨折处骨痂形成明显加速,骨痂灰度明显致密。结论肌注相应时段兔骨折合并脑外伤模型血清,能明显加速鼠单纯骨折模型的骨折愈合。 展开更多
关键词 骨折 脑外伤 异种动物模型 骨折愈合 实验研究
下载PDF
利用小鼠皮下人乳腺癌移植瘤模型观察MUC1-MBP抗乳腺癌作用 被引量:4
2
作者 宋献美 方芳 +3 位作者 马吉春 赵小霞 周静 台桂香 《免疫学杂志》 CAS CSCD 北大核心 2010年第5期428-432,共5页
目的建立小鼠皮下人乳腺癌移植瘤模型,探讨MUC1-MBP蛋白疫苗的抗人乳腺癌作用。方法首先通过筛选最佳条件建立小鼠皮下人乳腺癌移植瘤动物模型,HE染色和免疫组化鉴定。利用已经建立的乳腺癌动物模型,通过肿瘤预防实验和治疗实验,观察MUC... 目的建立小鼠皮下人乳腺癌移植瘤模型,探讨MUC1-MBP蛋白疫苗的抗人乳腺癌作用。方法首先通过筛选最佳条件建立小鼠皮下人乳腺癌移植瘤动物模型,HE染色和免疫组化鉴定。利用已经建立的乳腺癌动物模型,通过肿瘤预防实验和治疗实验,观察MUC1-MBP抗人乳腺癌作用。结果通过5 Gy X射线照射,皮下注射MCF-7人乳腺癌细胞3×10~6个/只,FTY720灌胃4~6 d,成功建立小鼠皮下人乳腺癌移植瘤动物模型。在预防乳腺癌生长实验中,PBS对照组、MBP组和MUC1-MBP组小鼠成瘤率分别为100%、83%和67%,肿瘤平均体积分别为(91.9±56.3)mm^3、(22.3±21.5)mm^3和(17.2±18.0)mm^3。与对照组相比,MUC1-MBP组显著减小(P<0.001),MBP组明显减小(P<0.05),提示MUC1-MBP能明显预防乳腺癌生长,MBP对乳腺癌生长也有一定的预防作用。在治疗乳腺癌生长实验中,PBS对照组、MBP组和MUC1-MBP组小鼠肿瘤生长抑制率分别为0、17%和17%,肿瘤平均体积分别为:(101.7±73.6)mm^3、(56.9±56.7)mm^3和(32.6±32.3)mm^3,与对照组相比,MUC1-MBP组明显减小(P<0.05),差异显著,提示MUC1-MBP对乳腺癌具有治疗作用。MBP组无显著差异(P>0.05),无统计学意义,提示MUC1-MBP对乳腺癌具有治疗作用。肿瘤组织HE染色结果发现,MUC1-MBP和MBP免疫组小鼠肿瘤组织周围及癌细胞间淋巴细胞浸润较PBS组明显增多。结论成功建立ICR小鼠皮下人乳腺癌移植瘤模型,该模型为肿瘤疫苗活性研究提供良好的研究工具。利用该模型发现MUC1-MBP免疫明显抑制小鼠皮下人乳腺癌的生长,MBP免疫也具有一定的抗乳腺癌生长作用,其能明显增强MUC1的免疫原性。 展开更多
关键词 人乳腺癌 移植肿瘤动物模型 MUC1-MBP 肿瘤疫苗
下载PDF
Setting up the Model of Xeno-graft Verse Host Disease
3
作者 夏国伟 张元芳 丁强 《Journal of Nanjing Medical University》 2004年第1期32-35,共4页
Objective: To observe human to mouse one way mixed lymphocyte(MLC); And to set up the xeno-grats verse host disease Xeno-graft host disease(XGVHD) model,probing its immunologic mechamism.Methods: Mouse splenic lympho... Objective: To observe human to mouse one way mixed lymphocyte(MLC); And to set up the xeno-grats verse host disease Xeno-graft host disease(XGVHD) model,probing its immunologic mechamism.Methods: Mouse splenic lymphocyte were collected in asepsis and treated by mitomycin as activating cell. Human Peripheral blood lymphocytes (hPBL)were separated and gathered as reacting cell; Mouse splenic lymphocyte and hPBL were mixed to incubate for a week. Destroying recipient (mouse) immune system by total body irradiation (TBI) and intraperitoneal injecting CTX、MTX; Separating and collecting hPBL; Injecting hPBL to mouse by caudal vein. Results; ①HPBL in the experiment groups(mixed mouse lymphocyte) proliferated obviously, the amount of 3H-TdR in corporation increased evidently(P<0.05); The mean percentage of CD 4、CD 8、IgG 、IgM positive cells rose markedly. ②Experiment groups,the hPBL were found in the spleen and kidney tissue, fas protein expressing, we occasionally discovered and apoptosis cells.Conclusion: The human to mouse one-way MLC has obvious lymphocyte proliferation. By these means,we succeed in inducing XGVHD and setting up a XGVHD model. 展开更多
关键词 senograft one-way mixed lymphocyte Xeno-graft host disease total body irradiation
下载PDF
Generation of human/rat xenograft animal model for the study of human donor stem cell behaviors in vivo 被引量:1
4
作者 Yan Sun Dong Xiao +3 位作者 Xing-Hua Pan Ruo-Shuang Zhang Guang-Hui Cui Xi-Gu Chen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第19期2707-2716,共10页
AIM: TO accurately and realistically elucidate human stem cell behaviors in vivo and the fundamental mechanisms controlling human stem cell fates in vivo, which is urgently required in regenerative medicine and treat... AIM: TO accurately and realistically elucidate human stem cell behaviors in vivo and the fundamental mechanisms controlling human stem cell fates in vivo, which is urgently required in regenerative medicine and treatments for some human diseases, a surrogate human-rat chimera model was developed. METHODS: Human-rat chimeras were achieved by in utero transplanting low-density mononuclear cells from human umbilical cord blood into the fetal rats at 9-11 d of gestation, and subsequently, a variety of methods, including flow cytometry, PCR as well as immunohistochemical assay, were used to test the human donor contribution in the recipients. RESULTS: Of 29 live-born recipients, 19 had the presence of human CD45^+ cells in peripheral blood (PB) detected by flow cytometry, while PCR analysis on genomic DNA from 11 different adult tissues showed that 14 selected from flow cytometry-positive 19 animals possessed of donor-derived human cell engraftment in multiple tissues (i.e. liver, spleen, thymus, heart, kidney, blood, lung, muscle, gut and skin) examined at the time of tissue collection, as confirmed by detecting human 132- microglobulin expression using immunohistochemistry. Tn this xenogeneic system, the engrafted donor-derived human cells persisted in multiple tissues for at least 6 mo after birth. Moreover, transplanted human donor cells underwent site-specific differentiation into CK18-positive human cells in chimeric liver and CEHS-positive human cells in chimeric spleen and thymus of recipients. CONCLUSION: Taken together, these findings suggest that we successfully developed human-rat chimeras, in which xenogeneic human cells exist up to 6 mo later. This humanized small animal model, which offers an in vivo environment more closely resembling to the situations in human, provides an invaluable and effective approach for in vivo investigating human stem cell behaviors, and further in vivo examining fundamental mechanisms controlling human stem cell fates in the future. The potential for new advances in our better understanding the living biological systems in human provided by investigators in humanized animals will remain promising. 展开更多
关键词 Human umbilical cord blood-derived cells In utero xenogeneic transplantation Human-rat chimeras Embryonic microenvironment In vivo model
下载PDF
EXPRESSION OF ICAM-1 AND LFA-1 MOLECULES IN RELATION TO RENAL ALLOGRAFT REJECTION IN RATS 被引量:3
5
作者 黄孝伦 沈文律 +2 位作者 李幼平 周泽清 谭建三 《Chinese Medical Sciences Journal》 CAS CSCD 1999年第3期163-166,共4页
Objective.The purpose of this study was to assess the renal graft expression of ICAM 1(intercellular adhesion molecule 1) and LFA 1(lymphocyte function associated antigen 1)molecule with rela... Objective.The purpose of this study was to assess the renal graft expression of ICAM 1(intercellular adhesion molecule 1) and LFA 1(lymphocyte function associated antigen 1)molecule with relation to graft rejection. Methods.Rat kidney transplantation was performed according to the procedure of Kamada with some modification.Experimental rats were divided into 5 groups.The survival time of recipient rats and function of grafts after renal transplantation were observed.The sections of renal graft were stained for monoclonal antibody ICAM 1 and LFA 1, and then quantification of ICAM 1 and LFA 1 expression was accomplished by computer image analysis. Results.ICAM 1 and LFA 1 increased significantly in the renal allograft rejection group as compared with the non rejection groups(P<0 05). Conclusion.Both biopsy of renal graft and monitoring of ICAM 1 and LFA 1 are useful tools in diagnosing and treating acute rejection. 展开更多
关键词 renal transplantation graft rejection ICAM 1 LFA 1
下载PDF
Interference RNA induction and drug target validation
6
作者 金鑫 孙婷婷 +5 位作者 王琪 徐欢 魏铁军 贺秋晨 张礼和 周德敏 《Journal of Chinese Pharmaceutical Sciences》 CAS 2009年第4期293-301,共9页
The ability to knockdown the expression of an endogenous gene by RNAi has emerged as a powerful strategy for the rapid identification of specific gene functions. Vector-based constitutive expression of shRNA can resul... The ability to knockdown the expression of an endogenous gene by RNAi has emerged as a powerful strategy for the rapid identification of specific gene functions. Vector-based constitutive expression of shRNA can result in stable and efficient knockdown of target genes. However, constitutive expression of shRNA imposes major limitations when analyzing the fimction of genes whose expression is vital for the survival of an organism. Inducible RNAi systems can circumvent this limitation by enabling the inhibition of expression of an essential gene only when the inducing agent is present, and the level of knockdown of the essential gene can be controlled and adjusted by the concentration of inducing agent. In this review, we briefly summarize the recent development of various inducible RNAi systems and their potential applications in drug target validation. 展开更多
关键词 RNA interference Stable transduction Inducible RNAi Target validation Xenograft animal model
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部